The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 29, 2021
Filed:
Feb. 06, 2018
Applicant:
Oncomed Pharmaceuticals, Inc., Redwood City, CA (US);
Inventors:
Christopher Lamond Murriel, San Francisco, CA (US);
Timothy Charles Hoey, Hillsborough, CA (US);
Austin L. Gurney, San Francisco, CA (US);
Julie Michelle Roda, Foster City, CA (US);
Minu K. Srivastava, Sunnyvale, CA (US);
Inkyung Park, Palo Alto, CA (US);
Jakob Dupont, Hillsborough, CA (US);
Assignee:
ONCOMED PHARMACEUTICALS, INC., Redwood City, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01); C07K 16/28 (2006.01); A61K 31/282 (2006.01); A61K 31/519 (2006.01); C07K 14/475 (2006.01); C07K 16/22 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 31/282 (2013.01); A61K 31/519 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); C07K 16/2803 (2013.01); C07K 16/2827 (2013.01); C12N 15/113 (2013.01); C12N 15/1136 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); A61K 2039/572 (2013.01); C07K 14/475 (2013.01); C07K 16/22 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C12N 15/11 (2013.01);
Abstract
The present invention provides methods comprising combination therapy for modulating immune responses, for inhibiting tumor growth, and/or for treating cancer. In particular, the present invention provides Notch pathway inhibitors in combination with immunotherapeutic agents for the treatment of cancer and other diseases.